close

Enter

Log in using OpenID

Small Molecule API Market

embed
A Small molecule Active Pharmaceutical Ingredient (API) is a low molecular weight organic compound, which may help to control biological process, with a size on the order of 1 nm.
Small Molecule API Market - Size, Share, Outlook,
and Opportunity Analysis, 2018- 2026
A Small molecule Active Pharmaceutical Ingredient (API) is a low molecular weight organic
compound, which may help to control biological process, with a size on the order of
1 nm. Most of the small molecule can be administered orally and are most likely to be
absorbed by the body. Owing to its small size it has properties of rapid diffusibility to reach at
intracellular site of action.
Get Sample Copy At: https://www.coherentmarketinsights.com/insight/request-sample/2423
Small Molecule API Market – Dynamics
The small molecule API market is witnessing rapid growth due to increasing number of
corporate agreements. For instance, BASF Pharma will sell its OMEGA 3 manufacturing facility
in Norway to Marine Ingredients. The Highly Potent Active Pharmaceutical Ingredients (HPAPI)
is projected to witness high growth rate, owing to easy access to the people for medication in
emerging economies. The rising prevalence of diseases such as cancer, cardiovascular, and
infectious diseases is expected to propel demand for manufacturing of small molecule APIs.
According to the National Center for Biotechnology Information (NCBI) report, in 2014, out of
570,341 deaths 29.4% were due to cancer and 27.1% were due to cardiovascular disease.
Increasing consumer awareness, benefits of small molecule API, expiry of patents covering the
top-selling pharmaceuticals, and technological advancement in manufacturing sector are
expected to drive the market growth over the forecast period. Increasing adoption of generic
drugs has resulted into affordable healthcare expenditure, which is expected to increase
production of small molecule API’s, in turn driving the global small molecule API market
growth. According to the Indian Brand Equity Foundation (IBEF), in 2018, India is largest
producer of generic medicines, which supplies 50% of vaccines and 40% of drugs to the U.S.
and 25% of drugs to the U.K.
Report includes chapters which deeply display the following deliverable about industry :
• Small Molecule API Market Research Objective and Assumption
• Small Molecule API Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Small Molecule API Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Small Molecule API Market, By Regions
• Small Molecule API Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Small Molecule API Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Small Molecule API Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Small Molecule API Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Small Molecule API Market – Regional insights
North America held the largest market share for small molecule API registering for 38.84% in
2017, due to high adoption rate of accelerated regulatory review of innovative medicines. Asia
Pacific excluding Japan (APEJ) market is estimated to witness rapid growth in market, owing to
high adoption of over the counter (OTC) drugs by large patient population coupled with
growing healthcare and pharmaceutical industry and strong research and development in API.
According to IBEF, investment in research and development by Indian pharmaceutical companies
increased (in term of sales) from 5.3% to 8.5% from 2012 to 2018.
Small Molecule API Market – Competitive landscape
The major player operating in global small molecule API market include ALLERGAN, Aurobindo
Pharma, Cambrex Corporation, Albemarle Corporation, D.r. Reddy’s Laboratories Ltd. The other
key players in market are Johnson Matthey, Siegfried Holding AG, Pfizer, Sanofi S.A., Novartis
AG, Johnson & Johnson, Bristol-Myers Squibb, Bachem Holding AG, Boehringer Ingelheim
GmbH, F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC, GILEAD Science Inc., Albany
Molecular Research Inc., Sun Pharmaceuticals, AstraZeneca, Merck & Co, Inc., BASF SE, and
Teva Pharmaceuticals. In March 2012, the FDA approved Ilumya (Tildrakizumab-asmn)
developed by Sun Pharmaceuticals used for Plaque Psoriasis.
Browse Complete Report For More Information @
https://www.coherentmarketinsights.com/market-insight/small-molecule-api-market-2423
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Author
Alex Huge
Alex Huge301   document Email
Document
Category
Health and Medicine
Views
2
File Size
109 KB
Tags
molecule, Small Molecule API Market
1/--pages
Report inappropriate content